Zhejiang, China

Wei Pang

This inventor holds 2 USPTO granted patents. Top assignees: Adlai Nortye Biopharma Co., Ltd., Xiamen Biotime Biotechnology Co., Ltd.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Pang. Retrieved from https://idiyas.com/inventor/wei-pang-29v11hdr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Wei Pang and His Innovative Contributions

Introduction

Wei Pang is an accomplished inventor based in Zhejiang, China, recognized for his significant contribution to biotechnology. His work primarily focuses on developing innovative compounds that have the potential to impact various fields, particularly in medicinal chemistry.

Latest Patents

Among his notable achievements, Wei Pang holds a patent for a highly active CSF1R inhibitor compound. This invention specifically relates to a CSF1R inhibitor, with the compound demonstrating exceptional inhibitory activity targeting CSF1R. The compound is characterized by its unique structure, designated as formula (I), which underscores the innovation behind its design and functionality.

Career Highlights

Wei Pang is currently affiliated with Xiamen Biotime Biotechnology Co., Ltd., a company known for its advanced research in biotechnological solutions. His role requires a deep understanding of both chemistry and biological mechanisms, enabling him to formulate effective compounds that meet the demands of the healthcare industry.

Collaborations

Throughout his career, Wei has collaborated with several notable scientists, including Shifeng Liu and Zhiyong Yu. These partnerships have fostered an environment of knowledge exchange and innovation, leading to advancements in their respective fields.

Conclusion

As an inventor, Wei Pang's contributions, particularly in the realm of CSF1R inhibitors, are paving the way for future innovations in biotechnology. His dedication to research and collaboration with peers highlights the importance of teamwork in achieving groundbreaking advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…